NewEdge Advisors’s Virtus LifeSci Biotech Clinical Trials ETF BBC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $97 | Hold |
5
| – | – | ﹤0.01% | 3907 |
|
|
2025
Q1 | $88 | Hold |
5
| – | – | ﹤0.01% | 3830 |
|
|
2024
Q4 | $120 | Hold |
5
| – | – | ﹤0.01% | 3775 |
|
|
2024
Q3 | $140 | Hold |
5
| – | – | ﹤0.01% | 3702 |
|
|
2024
Q2 | $126 | Hold |
5
| – | – | ﹤0.01% | 3679 |
|
|
2024
Q1 | $146 | Hold |
5
| – | – | ﹤0.01% | 3687 |
|
|
2023
Q4 | $122 | Hold |
5
| – | – | ﹤0.01% | 3629 |
|
|
2023
Q3 | $98 | Hold |
5
| – | – | ﹤0.01% | 3367 |
|
|
2023
Q2 | $120 | Hold |
5
| – | – | ﹤0.01% | 3413 |
|
|
2023
Q1 | $110 | Hold |
5
| – | – | ﹤0.01% | 3338 |
|
|
2022
Q4 | $0 | Buy |
+5
| New | – | ﹤0.01% | 4090 |
|